Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
STEMDATA
Show more
Class 9: a consortium data sharing, analytics, and communication computer software platform that enables physicians, healthcare professionals, researchers in the field of Immunotherapy, cellular therapy and blood and marrow transplantation and manufacturers of cellular and immuno-therapies to analyze, collaborate, communicate, and share patient outcomes data
Class 42: Platform as a service (PAAS) featuring a consortium data sharing, analytics, and communication software platform that enables physicians, healthcare professionals, researchers in the field of immunotherapy, cellular therapy and blood and marrow transplantation and manufacturers of cellular and immuno-therapies to analyze, collaborate, communicate and share patient outcomes data
Class 9 – Software, electronics & scientificClass 42 – Technology & SaaS
Status timeline
- 29 Jan 2019Assigned to an examining attorneyAssigned To Examiner
- 5 Feb 2019Office action issuedNon-Final Action Written
- 11 Jul 2019Response to office action filedTeas Response To Office Action Received
- 16 Aug 2019Office action issuedNon-Final Action Written
- 16 Feb 2020Response to office action filedTeas Response To Office Action Received
- 29 Feb 2020Approved for registration (Supplemental Register)Approved For Registration Supplemental Register
- 7 Apr 2020Registered on the Supplemental RegisterRegistered-Supplemental Register
All 27 events
| 2025-04-07 | Rem1 |
| 2020-04-07 | Registered-Supplemental Register |
| 2020-03-03 | Law Office Publication Review Completed |
| 2020-02-29 | Approved For Registration Supplemental Register |
| 2020-02-18 | Correspondence Received In Law Office |
| 2020-02-18 | Teas/Email Correspondence Entered |
| 2020-02-16 | Teas Response To Office Action Received |
| 2020-02-16 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2020-02-16 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2020-02-16 | Teas Change Of Correspondence Received |
| 2019-08-16 | Non-Final Action Written |
| 2019-08-16 | Non-Final Action E-Mailed |
| 2019-08-16 | Notification Of Non-Final Action E-Mailed |
| 2019-07-26 | Notice Of Acceptance Of Amendment To Allege Use E-Mailed |
| 2019-07-25 | Use Amendment Accepted |
| 2019-07-24 | Correspondence Received In Law Office |
| 2019-07-24 | Teas/Email Correspondence Entered |
| 2019-07-18 | Assigned To Lie |
| 2019-07-11 | Teas Response To Office Action Received |
| 2019-07-05 | Use Amendment Filed |
| 2019-07-05 | Amendment To Use Processing Complete |
| 2019-07-04 | Teas Amendment Of Use Received |
| 2019-02-05 | Non-Final Action Written |
| 2019-02-05 | Non-Final Action E-Mailed |
| 2019-02-05 | Notification Of Non-Final Action E-Mailed |
| 2019-01-29 | Assigned To Examiner |
| 2018-11-01 | New Application Office Supplied Data Entered |
Goods & services by class
Class 9 Software, electronics & scientific
a consortium data sharing, analytics, and communication computer software platform that enables physicians, healthcare professionals, researchers in the field of Immunotherapy, cellular therapy and blood and marrow transplantation and manufacturers of cellular and immuno-therapies to analyze, collaborate, communicate, and share patient outcomes data
First use anywhere 30 Mar 2019 · First use in commerce 30 Mar 2019
Class 42 Technology & SaaS
Platform as a service (PAAS) featuring a consortium data sharing, analytics, and communication software platform that enables physicians, healthcare professionals, researchers in the field of immunotherapy, cellular therapy and blood and marrow transplantation and manufacturers of cellular and immuno-therapies to analyze, collaborate, communicate and share patient outcomes data
First use anywhere 30 Mar 2019 · First use in commerce 30 Mar 2019
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 7 Apr 2020; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.